Thread

HOW ELaiGIBLE CT contributes to the SUSTAINABLE DEVELOPMENT GOALS ELaiGIBLE CT is a pioneering product developed by OASYS NOW that is fundamentally transforming the process of patient eligibility pre-screening for clinical trials. By leveraging advanced Explainable Artificial Intelligence (XAI), ELaiGIBLE addresses the critical bottleneck in medical research: the slow, costly, and often manual task of identifying suitable patients from complex, disparate health data. ELaiGIBLE contributes: Societal Impact and Inclusivity: Beyond its technological advancements, ELaiGIBLE is designed with a profound societal impact, focused on fairness, speed, and access to cutting-edge medicine. Increased Inclusivity and Fairness: By scanning every available data source—not just clean, structured fields—ELaiGIBLE ensures No Patients Are Missed. This capability is vital for including previously underrepresented groups in clinical trials, making the research process fairer and the resulting treatments relevant to a broader population. Accelerated Patient Access: By drastically increasing recruitment speed, the platform facilitates getting critical, new treatment options to patients and their families faster. This acceleration is crucial in time-sensitive fields, offering hope where traditional methods cause delays. Privacy-First Design: Recognizing the sensitivity of health data, the product is built on a Certified Privacy-First Infrastructure, adhering to rigorous standards like ISO 27001 and NEN 7510. It features one of the most extensive pseudonymisation pipelines on the market, ensuring that patient data is handled securely and responsibly—a commitment that earned it the Dutch Privacy Award.